Alexander Scott Moffett

Alexander Scott Moffett

Auto-generated profile, based on publicly available information

Alexander Scott Moffett

Center for Theoretical Biological Physics, Northeastern University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZSZahra Shamsi
Zahra Shamsi
AMAlexander S. Moffett
Alexander S. Moffett
DSDiwakar Shukla
Diwakar Shukla
One of the major challenges in atomistic simulations of proteins is efficient sampling of pathways associated with rare conformational transitions. Recent developments in statistical methods for computation of direct evolutionary couplings between amino acids within and across polypeptide chains have allowed for inference of native residue contacts, informing accurate prediction of protein folds and multimeric structures. In this study, we assess the use of distances between evolutionarily coupled residues as natural choices for reaction coordinates which can be incorporated into Markov state model-based adaptive sampling schemes and potentially used to predict not only functional conformations but also pathways of conformational change, protein folding, and protein-protein association. We demonstrate the utility of evolutionary couplings in sampling and predicting activation pathways of the β2-adrenergic receptor (β2-AR), folding of the FiP35 WW domain, and dimerization of the E. coli molybdopterin synthase subunits. We find that the time required for β2-AR activation and folding of the WW domain are greatly diminished using evolutionary couplings-guided adaptive sampling. Additionally, we were able to identify putative molybdopterin synthase association pathways and near-crystal structure complexes from protein-protein association simulations.

1 July 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AMAlexander S. Moffett
Alexander S. Moffett
KBKyle W. Bender
Kyle W. Bender
SHSteven C. Huber
Steven C. Huber
DSDiwakar Shukla
Diwakar Shukla
The structural motifs responsible for activation and regulation of eukaryotic protein kinases in animals have been studied extensively in recent years, and a coherent picture of their activation mechanisms has begun to emerge. On the other hand, non-animal eukaryotic protein kinases are not as well understood from a structural perspective, representing a large knowledge gap. To this end, we investigated the conformational dynamics of two key Arabidopsis thaliana receptor-like kinases, brassi- nosteroid insensitive 1 (BRI1) and BRI1-associated kinase 1 (BAK1), through extensive molecular dynamics (MD) simulations of their fully phosphorylated kinase domains. MD simulations calculate the motion of each atom in a protein based on classical approximations of interatomic forces, giving researchers insight into protein function at unparalleled spatial and temporal resolutions. We found that in an otherwise ″active″ BAK1, the αC helix is highly disordered, a hallmark of deactivation, while the BRI1 αC helix is moderately disordered and displays swinging behavior similar to numerous animal kinases. An analysis of all known sequences in the A. thaliana kinome found that αC helix disorder may be a common feature of plant kinases.

1 December 2017 in Biophysical Journal
Verified
Journal Article
Closed access
AMAlexander S. Moffett
Alexander S. Moffett
KBKyle W. Bender
Kyle W. Bender
SHSteven C. Huber
Steven C. Huber
DSDiwakar Shukla
Diwakar Shukla

9 March 2018 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
AMAlexander S. Moffett
Alexander S. Moffett
DSDiwakar Shukla
Diwakar Shukla
Eukaryotic protein kinases (PKs) are a large family of proteins critical for cellular response to external signals, acting as molecular switches. PKs propagate biochemical signals by catalyzing phosphorylation of other proteins, including other PKs, which can undergo conformational changes upon phosphorylation and catalyze further phosphorylations. Although PKs have been studied thoroughly across the domains of life, the structures of these proteins are sparsely understood in numerous groups of organisms, including plants. In addition to efforts towards determining crystal structures of PKs, research on human PKs has incorporated molecular dynamics (MD) simulations to study the conformational dynamics underlying the switching of PK function. This approach of experimental structural biology coupled with computational biophysics has led to improved understanding of how PKs become catalytically active and why mutations cause pathological PK behavior, at spatial and temporal resolutions inaccessible to current experimental methods alone. In this review, we argue for the value of applying MD simulation to plant PKs. We review the basics of MD simulation methodology, the successes achieved through MD simulation in animal PKs, and current work on plant PKs using MD simulation. We conclude with a discussion of the future of MD simulations and plant PKs, arguing for the importance of molecular simulation in the future of plant PK research.

24 December 2019 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
FAFaisal Aldukhi
Faisal Aldukhi
ADAniket Deb
Aniket Deb
CZChuankai Zhao
Chuankai Zhao
AMAlexander Scott Moffett
Alexander Scott Moffett
DSDiwakar Shukla
Diwakar Shukla

7 July 2015 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
SKSahir Kalim
Sahir Kalim
CCClary Clish
Clary Clish
JDJoseph J. Deferio
Joseph J. Deferio
GOGuillermo Ortiz
Guillermo Ortiz
AMAlexander S. Moffet
Alexander S. Moffet
EREugene P. Rhee
Eugene P. Rhee
Although metabolomic approaches have begun to document numerous changes that arise in end stage renal disease (ESRD), how these alterations relate to established metabolic phenotypes in uremia is unknown. In 200 incident hemodialysis patients we used partial least squares discriminant analysis to identify which among 166 metabolites could best discriminate individuals with or without diabetes, and across tertiles of body mass index, serum albumin, total cholesterol, and systolic blood pressure. Our data do not recapitulate metabolomic signatures of diabetes and obesity identified among individuals with normal renal function (e.g. elevations in branched chain and aromatic amino acids) and highlight several potential markers of diabetes status specific to ESRD, including xanthosine-5-phosphate and vanillylmandelic acid. Further, our data identify significant associations between elevated tryptophan and long-chain acylcarnitine levels and both decreased total cholesterol and systolic blood pressure in ESRD. Higher tryptophan levels were also associated with higher serum albumin levels, but this may reflect tryptophan’s significant albumin binding. Finally, an examination of the uremic retention solutes captured by our platform in relation to 24 clinical phenotypes provides a framework for investigating mechanisms of uremic toxicity. In sum, these studies leveraging metabolomic and metabolic phenotype data acquired in a well-characterized ESRD cohort demonstrate striking differences from metabolomics studies in the general population, and may provide clues to novel functional pathways in the ESRD population.